In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 3, 1998, Pages 354-357

  Pradines, B ^a   Rogier, C ^a,b   Fusai, T ^a   Tall, A ^b   Trape, J F ^c   Doury, J C ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c Laboratoire de Paludologie Campus International UCAD IRD Hann   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; SENEGAL;

EID: 0031900723     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.354     Document Type: Article

References (34)

1. Wernsdorfer WH, 1991. The development and spread of drugresistant malaria. Parasitol Today 7: 297-303.
2. Klayman DL, 1955. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055.
3. Meshnick SR, Tsang TW, Lin FB, Pan HZ, Chang CN, Kuypers F, Chiu D, Lubin D, 1989. Activated oxygen mediates the antimalarial activity of qinghaosu. Prog Clin Biol Res 313: 95-104.
4. Karbwang J, Na-Bangchang K, Thanavibul A, Laothavom P, Ditta-In M, Harinasuta T, 1995. A comparative clinical trial of artemether and the sequential regimen of artemether-mefloquine in multidrug resistant falciparum malaria. J Antimicrob Chemother 36: 1079-1083.
5. Karbwang J, Tin T, Pimchia W, Sukontason K, Namsiripongpun V, Thanavibul A, Na-Bangchang K, Laothavom P, Bunnag D, Harinasuta T, 1995. Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand. Trans R Soc Trop Med Hyg 89: 668-671.
6. Doury JC, Ringwald P, Guelain J, Le Bras J, 1992. Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu). Trop Med Parasitol 43: 197-198.
7. Hassan Alin M, Kihamia CM, Bjorkman A, Bwijo BA, Premji Z, Mtey GJB, Ashton M, 1995. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Am J Trop Med Hyg 53: 639-645.
8. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Dauilhe P, Pereira da Silva L, 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
9. Rogier C, Trape JF, 1996. Etude de l'acquisition de la premunison en zones d'holo et mesoendemie palustre a Dielmo et a Ndiop (Senegal). Resultats preliminaires, 1990-1994. Med Trop 55 (suppl): 71-76.
10. Le Bras J, Deloron P, 1983. In vitro study of drug sensitivity of Plasmodium falciparum: an evaluation of a new semi-microtest. Am J Trop Med Hyg 32: 447-451.
11. Basco LK, Le Bras J, 1993. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 49: 301-307.
12. Ringwald P, Bickii J, Basco LK, 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 55: 254-258.
13. Shanks GD, Watt G, Edstein MD, Webster K, Suriyamongkol V, Watanasook C, Panpunnung S, Kowinwiphat W, 1991. Halofantrine for the treatment of mefloquine chemoprophylaxis failure in Plamodium falciparum infections. Am J Trop Med Hyg 45: 488-491.
14. Gay F, Bustos DG, Diquet B, Rivero LR, Litaudon M, Pichet C, Danis M, Gentilini M, 1990. Cross-resistance between mefloquine and halofantrine (letter). Lancet 336: 1262.
15. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC, 1996. Sensibilite in vitro de 85 isolats de Plasmodium falciparum au Senegal. Med Trop 56: 141-145.
16. Basco LK, Le Bras J, Gillotin C, Ringwaid P, Rabenjarson E, Gimenez F, Bouchaud O, Farinitti R, Coulaud JP, 1991. Type RI resistance to halofantrine in West Africa. Trop Med Parasitol 42: 413-414.
17. Gay F, Binet MH, Bustos MDG, Rouveix B, Danis M, Roy C, Gentilini M, 1990. Mefloquine failure in a child contracting falciparum malaria in West Africa. Lancet 335: 120-121.
18. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P 1992. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988 II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg 46: 8-14.
19. Fitch CD, 1986. Antimalarial schizonticides: ferriprotoporphyrin IX interaction hypothesis. Parasitol Today 2: 330-331.
20. Slater AFG, Cerami A, 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169.
21. Meshnick SR, Thomas A, Ranz A, Xu CM, Pan HZ, 1991. Artemisinin (qinghaosu): the role of intraceilular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol 49: 181-190.
22. Zhang Y, Gosser DK, Meshnick SR, 1992. Hemin-catalysed decomposition of artemisinin (qinghaosu). Biochem Pharmacol 43: 1805-1809.
23. Hong YL, Yang YZ, Meshnick SR, 1994. The interaction of artemisinin with malaria hemozoin. Mol Biochem Parasitol 63: 121-128.
24. Wei N, Sadrzadeh SMH, 1994. Enhancement of hemin-induced membrane damage by artemisinin. Biochem Pharmacol 48: 737-741.
25. Chevli R, Fitch CD, 1982. The antimalarial drug mefloquine binds to membrane phospholipids. Antimicrob Agents Chemother 21: 581-586.
26. 3H-dihydroartemisinin by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 78: 265-270.
27. Edwards G, Ward S, Breckenenridge A, 1992. Interaction of artemether with the red blood cell in vitro and its possible importance in the interpretation of plasma concentration in vivo. J Pharm Pharmacol 44: 280-281.
28. Cowman AF, Galatis D, Thompson JK, 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of Pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
29. Mockenhaupt FP, 1995. Mefloquine resistance in Plasmodium falciparum. Parasitol Today 11: 248-253.
30. Luxemburger C, Nosten F, Shotar D, Raimond D, Chongsuphajaisiddhi T, White NJ, 1995. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 53: 522-525.
31. Nosten F, Luxemburger C, ter Kuile F, Woodrow C, Chongsuphajaisiddhi T, White NJ, 1994. Optimum artesunate-mefloquine combination for the treatment of multi-drug resistant P. falciparum malaria. J Infect Dis 170: 971-977.
32. Price RN, Nosten F, Luxemhurger C, Am Kham, Brockman A, Chongsuphajaisiddhi T, White NJ, 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 523-527.
33. White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, Greenwood BM, 1992. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 339: 317-321.
34. Kombila M, Dufillot D, Hai Duong T, Ngou Milama E, Rondi ML, Koko J, de Beugny B, 1994. Traitement des acces palustres a Plasmodium falciparum de l'enfant par l'artemether au Gabon. Cah Sante 5: 19-23.